Edition:
United Kingdom

Concert Pharmaceuticals announces completion of enrollment in First Cohort of CTP-543 phase 2a trial


Monday, 6 Nov 2017 

Nov 6 (Reuters) - Concert Pharmaceuticals Inc :Concert Pharmaceuticals Inc announces completion of enrollment in First Cohort of CTP-543 phase 2a trial.Concert Pharmaceuticals Inc - ‍phase 2a trial on track to complete in second half of 2018​. 

Company Quote

10.75
-0.18 -1.65%
19 Jul 2019